English
Home > Products > 98071-16-0

China 98071-16-0 Factory

With superior technologies and facilities, strict quality command, reasonable cost, exceptional provider and close co-operation with customers, we've been devoted to delivering the best benefit for our buyers for 98071-16-0,CAS NO 98071-16-0,Apalutamide intermediate,Apalutamide advance intermediate,1-Amino-1-cyclobutanecarboxylic, We sincerely welcome friends to barter business enterprise and start cooperation with us. We hope to hitch hands with close friends in different industries to produce a brilliant long run.
98071-16-0, Each year, many of our customers would visit our company and achieve great business advancements working with us. We sincerely welcome you to visit us at any time and together we will prevail to a greater success in the hair industry.

Related Products

Hot Products

  • Fondaparinux sodium

    Fondaparinux sodium

    Product Name:Fondaparinux sodium
    Molecular Formula:C31H43N3O49S8.10Na
    Molecular Weight;1728.08
    CAS Registry Number;114870-03-0
  • 2-Chloro-4-fluorophenol

    2-Chloro-4-fluorophenol

    Product Name:2-Chloro-4-fluorophenol
    Molecular Formula:C6H4ClFO
    Molecular Weight:146.55
    CAS Registry Number:1996-41-4
  • H-ALA-ALA-OME HCL

    H-ALA-ALA-OME HCL

    Product Name:H-ALA-ALA-OME HCL
    Molecular Formula:C7H15ClN2O3
    Molecular Weight:210.66
    CAS Registry Number:41036-19-5
  • Hydrocortisone acetate

    Hydrocortisone acetate

    Product Name:Hydrocortisone acetate
    Molecular Formula:C23H32O6
    Molecular Weight:404.5
    CAS Registry Number;50-03-3
  • Ethyl (R)-(-)-4-cyano-3-hydroxybutyate

    Ethyl (R)-(-)-4-cyano-3-hydroxybutyate

    Product Name:Ethyl (R)-(-)-4-cyano-3-hydroxybutyate
    Molecular Formula:C7H11NO3
    Molecular Weight:157.17
    CAS Registry Number:141942-85-0
  • Ethyl 2-methylacetoacetate

    Ethyl 2-methylacetoacetate

    Product Name:Ethyl 2-methylacetoacetate
    Molecular Formula:C7H12O3
    Molecular Weight:144.17
    CAS Registry Number:609-14-3
  • Related Blog
  • Reviews

  • Tofacitinib More Effective, Alone and in Combinations, than Non-biologic DMARDS

    Tofacitinib (marketed under the brand name Xeljanz) is an oral Janus kinase inhibitor currently approved for the treatment of RA. It was developed in a unique public-private partnership between the National Institutes of Health...

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    API is fundamental to the modern drug manufacturing process and cutting cost should not be the only criteria that can be applied to the production of an active pharmaceutical ingredient as it can adversely affect human health if the above-mentioned regulations and practices are not followed strictly.

  • Prostate Cancer and Darolutamide

    Prostate cancer results from uncontrollable growth of cancer cells in the prostate gland. The prostate gland is located below the bladder and in front of the rectum, and is only found in males. Almost all prostate cancers (more than 95% of primary prostate cancers) develop from the gland cells and are known as adenocarcinomas (National Cancer Institute, 2017).

  • Outsourcing of API Manufacturing – Are Strict Regulation and Quality Checks Necessary?

    Here are so many diseases that affect the human population in the current hours and so are the numerous drugs that are available to treat those diseases.

  • What Is Ursodeoxycholic Acid Used For?

    Ursodeoxycholic acid is a cholelithiant commonly used in the gastroenterology department, and also a cholelithiasis dissolving agent, so it can be used in the treatment of gallstones under normal circumstances, on the premise...

  • Development Trend of China's Pharmaceutical Intermediate Industry

    The rapid development of China's pharmaceutical intermediate industry is closely related to its national policies. Since 2016, China has issued clear documents to encourage small and medium-sized enterprises to develop new drugs, including chemical raw materials. At the same time, the structural upgrading of the pharmaceutical industry in developed countries has promoted the transfer of global related industrial chains and promoted China's chemical raw material drug supply chain. In addition, the increase in Chinese radiography technology has boosted product demand.

Related Search

CAS NO 98071-16-0

Send Inquiry

Hit enter to search or ESC to close
X
We use cookies to offer you a better browsing experience, analyze site traffic and personalize content. By using this site, you agree to our use of cookies. Privacy Policy
Reject Accept